Quaker Chemical closes $550 million term loan B refinancing, maturing October 2033
Quaker Chemical entered into an amendment to its credit agreement on October 1, 2026, creating a new $550 million seven-year term loan B facility. Proceeds will repay in full the U.S. Term Loans outstanding under the existing agreement, and the company said the deal extends its debt maturity profile and reduces required annual debt payments.
Key points
- $550 million term loan B facility matures October 1, 2033
- Interest at Term SOFR plus 1.750% for Term SOFR loans; quarterly amortization of 0.25% of initial principal
- Proceeds repay in full the U.S. Term Loans; their aggregate principal balance is $0 as of the amendment's effective date
- Facility is secured by first priority liens on substantially all assets and carries a 1.00% prepayment premium for a repricing event within six months
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 01, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.